These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1509607)

  • 21. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
    Furtado C; Pinto M
    Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD; Dufresne L; LeBlanc D
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.
    Siegel D; Lopez J
    JAMA; 1997 Dec; 278(21):1745-8. PubMed ID: 9388150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seventeen-Year Nationwide Trends in Antihypertensive Drug Use in Denmark.
    Sundbøll J; Adelborg K; Mansfield KE; Tomlinson LA; Schmidt M
    Am J Cardiol; 2017 Dec; 120(12):2193-2200. PubMed ID: 29054274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies.
    Buusman A; Kragstrup J; Andersen M
    Eur J Clin Pharmacol; 2005 Oct; 61(9):651-6. PubMed ID: 16187132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOPE study impact on ACE inhibitors use.
    Hemels ME; Bennett HA; Bonari L; Han D; Traverso ML; Einarson TR
    Ann Pharmacother; 2003 May; 37(5):640-5. PubMed ID: 12708937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Population analysis by area of health of changes in consumption, price and expenditure of cardiovascular drugs in eight autonomous communities, Spain, 2005].
    Sanfélix-Gimeno G; Peiró S; Librero J; Ausejo-Segura M; Suárez-Alemán C; Molina-López T; Concepción CM; Castaño-Riera E;
    Rev Esp Salud Publica; 2010; 84(4):389-407. PubMed ID: 21141266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rational prescribing and cost reduction in the treatment of arterial hypertension: a simulation exercise].
    Bonet A; Gosalbes V; Fito M; Navarro J
    Gac Sanit; 2001; 15(4):327-35. PubMed ID: 11578562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.
    Donohue JM; Fischer MA; Huskamp HA; Weissman JS
    Health Serv Res; 2008 Oct; 43(5 Pt 1):1557-75. PubMed ID: 18479406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparisons outpatient drug prescriptions: France, Denmark, Norway, Sweden].
    Dezileaux B; Martinez F
    Therapie; 2016 Jun; 71(3):297-305. PubMed ID: 27235653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns in drug utilization--national and international aspects: antihypertensive drugs.
    Baksaas I
    Acta Med Scand Suppl; 1984; 683():59-66. PubMed ID: 6146249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Method of estimating the disposition of drugs in the Danish population by sampling reimbursed prescriptions.
    Andreasen F; Bech A; Behrendt F; Madsen H; Moustgaard L; Nielsen M
    Eur J Clin Pharmacol; 1979 Nov; 16(5):361-7. PubMed ID: 520405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cardiovascular disease on pharmacokinetics.
    Rodighiero V
    Cardiovasc Drugs Ther; 1989 Oct; 3(5):711-30. PubMed ID: 2577313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pricing and costs of drugs in the United States and Sweden: a comparison based on drug acquisition costs at the patient outcome level.
    Melander A; Nilsson JL
    J Ambul Care Manage; 2004; 27(2):115-9. PubMed ID: 15069988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in drug treatment in the elderly between 1971 and 2000.
    Lernfelt B; Samuelsson O; Skoog I; Landahl S
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):637-44. PubMed ID: 12923602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives.
    Nilsson JL; Lindberg G; Johansson H; Melander A
    Eur J Clin Pharmacol; 2006 Aug; 62(8):675-80. PubMed ID: 16823583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Consumption of antacids and anticholinergic agents in Denmark. Relation to altered rules for subsidizing medicines].
    Koster A; Mosbech J
    Ugeskr Laeger; 1977 Mar; 139(12):710-1. PubMed ID: 847801
    [No Abstract]   [Full Text] [Related]  

  • 38. Rational use of medications: if Canada can't do it ..
    Califf RM
    CMAJ; 2009 Jul; 181(1-2):15-6. PubMed ID: 19581612
    [No Abstract]   [Full Text] [Related]  

  • 39. Twenty-Three-Year Trends in the Use of Potentially Nephrotoxic Drugs in Denmark.
    Enevoldsen FC; Christiansen CF; Jensen SK
    Clin Epidemiol; 2023; 15():275-287. PubMed ID: 36915868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Consumption of drugs: policies and social pact].
    Antoñanzas Villar F
    Gac Sanit; 2000; 14(2):93-6. PubMed ID: 11203054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.